DK443988A - Injektionspraeparat indeholdende modificeret tpa - Google Patents

Injektionspraeparat indeholdende modificeret tpa

Info

Publication number
DK443988A
DK443988A DK443988A DK443988A DK443988A DK 443988 A DK443988 A DK 443988A DK 443988 A DK443988 A DK 443988A DK 443988 A DK443988 A DK 443988A DK 443988 A DK443988 A DK 443988A
Authority
DK
Denmark
Prior art keywords
preparation containing
containing modified
injection preparation
modified tpa
tpa
Prior art date
Application number
DK443988A
Other languages
Danish (da)
English (en)
Other versions
DK443988D0 (da
Inventor
Masahiro Kawahara
Yuichiro Hayashi
Naoki Asakawa
Sumio Watanabe
Yasuo Miyake
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=16406817&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK443988(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of DK443988D0 publication Critical patent/DK443988D0/da
Publication of DK443988A publication Critical patent/DK443988A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK443988A 1987-08-10 1988-08-09 Injektionspraeparat indeholdende modificeret tpa DK443988A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62199381A JP2708749B2 (ja) 1987-08-10 1987-08-10 修飾型ｔＰＡ含有注射用組成物

Publications (2)

Publication Number Publication Date
DK443988D0 DK443988D0 (da) 1988-08-09
DK443988A true DK443988A (da) 1989-02-11

Family

ID=16406817

Family Applications (1)

Application Number Title Priority Date Filing Date
DK443988A DK443988A (da) 1987-08-10 1988-08-09 Injektionspraeparat indeholdende modificeret tpa

Country Status (11)

Country Link
US (1) US5425943A (es)
EP (1) EP0303251B1 (es)
JP (1) JP2708749B2 (es)
KR (1) KR910009366B1 (es)
AT (1) ATE84220T1 (es)
CA (1) CA1338699C (es)
DE (1) DE3877277T2 (es)
DK (1) DK443988A (es)
ES (1) ES2052651T3 (es)
GR (1) GR3006748T3 (es)
NO (1) NO178325C (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453363A (en) * 1985-10-23 1995-09-26 Boehringer Mannheim Gmbh Process for the activation of t-PA or Ing after genetic expression in prokaryotes
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
JP2520975B2 (ja) * 1989-09-21 1996-07-31 三井東圧化学株式会社 組織プラスミノ―ゲンアクチベ―タ―若しくはその誘導体を含有する血栓溶解剤
DE3939346A1 (de) * 1989-11-29 1991-06-06 Behringwerke Ag Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide
US6372716B1 (en) * 1994-04-26 2002-04-16 Genetics Institute, Inc. Formulations for factor IX
US5770700A (en) * 1996-01-25 1998-06-23 Genetics Institute, Inc. Liquid factor IX formulations
TWI240627B (en) * 1996-04-26 2005-10-01 Chugai Pharmaceutical Co Ltd Erythropoietin solution preparation
US6139838A (en) * 1996-09-06 2000-10-31 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Tissue plasminogen activator medicinal composition

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54147916A (en) * 1978-05-12 1979-11-19 Sumitomo Chem Co Ltd Preparation of urokinase injection
EP0125254A1 (en) * 1982-10-28 1984-11-21 Beecham Group Plc Enzyme derivatives and their use in the treatment of thrombosis
GB8334498D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Compounds
JPS60181028A (ja) * 1984-02-29 1985-09-14 Asahi Chem Ind Co Ltd 組織プラスミノ−ゲン・アクチベ−タ−の溶解補助法
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.
JPS60184026A (ja) * 1984-03-01 1985-09-19 Asahi Chem Ind Co Ltd 組織プラスミノ−ゲン・アクチベ−タ−の溶解補助方法
GB8503358D0 (en) * 1985-02-09 1985-03-13 Beecham Group Plc Compounds
GB8508717D0 (en) * 1985-04-03 1985-05-09 Beecham Group Plc Composition
GR861037B (en) * 1985-04-22 1986-07-16 Genentech Inc Novel human tissue plasminogen activator mutants
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
NZ217331A (en) * 1985-08-26 1989-05-29 Lilly Co Eli Tissue plasminogen activator derivatives and genetically engineered product
US4960702A (en) * 1985-09-06 1990-10-02 Codon Methods for recovery of tissue plasminogen activator
JPH0811066B2 (ja) * 1985-09-30 1996-02-07 インテグレーテッド・ジエネティックス・インコーポレーテッド 組換えｄｎａが生産するヒト子宮プラスミノ−ゲンアクチベ−タ−
JPH0672105B2 (ja) * 1985-10-02 1994-09-14 持田製薬株式会社 血栓溶解剤及びその製法
JPS62120321A (ja) * 1985-11-20 1987-06-01 Eisai Co Ltd ｔＰＡ含有医薬組成物
US4777043A (en) * 1985-12-17 1988-10-11 Genentech, Inc. Stabilized human tissue plasminogen activator compositions
DE3684680D1 (de) * 1985-12-23 1992-05-07 Chiron Corp Peptidplasminogenaktivatoren.
US4935237A (en) * 1988-03-21 1990-06-19 Genentech, Inc. Processes for the preparation of t-PA mutants
US4898826A (en) * 1987-12-10 1990-02-06 Invitron Corporation Method to solubilize tissue plasminogen activator

Also Published As

Publication number Publication date
EP0303251A2 (en) 1989-02-15
NO178325C (no) 1996-03-06
JP2708749B2 (ja) 1998-02-04
DK443988D0 (da) 1988-08-09
EP0303251B1 (en) 1993-01-07
ES2052651T3 (es) 1994-07-16
ATE84220T1 (de) 1993-01-15
KR910009366B1 (ko) 1991-11-14
CA1338699C (en) 1996-11-12
GR3006748T3 (es) 1993-06-30
KR890003404A (ko) 1989-04-14
EP0303251A3 (en) 1990-01-31
DE3877277D1 (de) 1993-02-18
US5425943A (en) 1995-06-20
JPS6442442A (en) 1989-02-14
NO178325B (no) 1995-11-27
NO883520D0 (no) 1988-08-08
DE3877277T2 (de) 1993-06-03
NO883520L (no) 1989-02-13

Similar Documents

Publication Publication Date Title
FI901421A0 (fi) N-(3-hydroxi-4-piperidinyl) (dihydrobenzofuran, dihydro-2h-benzopyran- eller dihydrobenzodioxin) karboxiamidderivat.
DK24389A (da) (cycloalkylamino)methylenbis(phosphonsyre) og farmaceutiske praeparater indeholdende forbindelsen
DK524187D0 (da) Aminosyrechelaterede midler til udlevering til specifikke biologiske vaevssteder
NZ236589A (en) A-nor-steroid-3-carboxylic acid derivatives and pharmaceutical compositions
SE8603582L (sv) Komposition innehallande l-dopa
DE68922405T2 (de) Deletionsanaloga von magaininpeptiden.
IT1187828B (it) Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
SE8404065D0 (sv) Novel biologically active compounds
DE3867445D1 (de) Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren.
DK443988D0 (da) Injektionspraeparat indeholdende modificeret tpa
PT86233A (fr) Procede de preparation d:une variant de l:hirudine
ATE65401T1 (de) Stabile, injizierbare loesungen von salzen von vincristin.
FI863078A0 (fi) Kontinuerligt frigoerande peptidkompositioner.
ATE92315T1 (de) Aminosaeurederivate enthaltende antikonvulsive zusammensetzungen und verwendung dieser aminosaeurederivate.
PT93991A (pt) Processo para a preparacao de solucoes estaveis de analogos de rebecamicina
HU896173D0 (es)
ATE10845T1 (de) Verfahren zur herstellung von n-(4-(((2,4-diamino-6-pteridinyl)methyl)methyla ino)benzoyl)- glutaminsaeure.
DE3578172D1 (de) 2,5-pyrrolidindion-derivate mit antiarrhythmischer wirkung.
IT8621283A0 (it) Sale di lisina dell'acido 4-bifenilacetico e sue compositioni oftalmiche.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment